BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12054573)

  • 1. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
    Kitazawa S; Kitazawa R
    Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
    Kitazawa R; Kitazawa S
    Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
    Liu J; Yang H; Liu W; Cao X; Feng X
    J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
    Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.
    Kitazawa S; Kajimoto K; Kondo T; Kitazawa R
    J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y; Abbas S; Hirayama T
    J Cell Biochem; 2004 Nov; 93(5):980-9. PubMed ID: 15389885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
    J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism.
    Frick KK; Bushinsky DA
    J Bone Miner Res; 2003 Jul; 18(7):1317-25. PubMed ID: 12854843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL expression is related to the differentiation state of human osteoblasts.
    Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC
    J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
    Kitazawa R; Kitazawa S
    Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.
    Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S
    J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
    Tian QX; Huang GY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):418-22. PubMed ID: 15379268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.